Free Trial
OTCMKTS:BICX

BioCorRx (BICX) Stock Price, News & Analysis

BioCorRx logo
$0.30 -0.02 (-6.25%)
As of 11:11 AM Eastern

About BioCorRx Stock (OTCMKTS:BICX)

Key Stats

Today's Range
$0.29
$0.30
50-Day Range
$0.29
$0.50
52-Week Range
$0.26
$1.45
Volume
7,739 shs
Average Volume
10,337 shs
Market Capitalization
$5.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

Receive BICX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioCorRx and its competitors with MarketBeat's FREE daily newsletter.

BICX Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
BioCorRx Inc. (BICX)
See More Headlines

BICX Stock Analysis - Frequently Asked Questions

BioCorRx's stock was trading at $0.38 at the beginning of 2025. Since then, BICX stock has decreased by 21.1% and is now trading at $0.30.
View the best growth stocks for 2025 here
.

BioCorRx Inc. (OTCMKTS:BICX) issued its quarterly earnings data on Thursday, May, 15th. The company reported ($0.06) earnings per share (EPS) for the quarter.

Shares of BICX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioCorRx investors own include PlayAGS (AGS), Ashford Hospitality Trust (AHT), Peabody Energy (BTU), Mondi (MNDI), Assertio (ASRT), Astronics (ATRO) and CONSOL Coal Resources (CCR).

Company Calendar

Last Earnings
5/15/2025
Today
5/27/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Specialty outpatient clinics, not elsewhere classified
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:BICX
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.77 million
Net Margins
-11,600.00%
Pretax Margin
-18,340.74%

Debt

Sales & Book Value

Annual Sales
$90,000.00
Price / Cash Flow
N/A
Book Value
($1.14) per share
Price / Book
-0.26

Miscellaneous

Free Float
11,920,000
Market Cap
$5.10 million
Optionable
Not Optionable
Beta
0.11

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (OTCMKTS:BICX) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners